Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.70 |
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.70 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.70 |
| ▸ | CASP1 | P29466 | 1/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.70 |
| ▸ | MAOA | P21397 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 2/20 | 0.56 |
| ▸ | SIGMAR1 | Q99720 | 10/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11777969 | 0.97 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL6680538 | 0.97 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL6379725 | 0.97 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL3625544 | 0.97 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL282602 | 0.97 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL2112457 | 0.97 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| Hydrochloric Acid SCHEMBL28408129 | 0.97 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL6683681 | 0.97 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL8500856 | 0.97 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| Iodide SCHEMBL8499688 | 0.93 | ALDH1A1 (0.61) | ALDH1A1HPGDALOX15ALOX12CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116406213-A | Chemical method for inhibiting ion diffusion in perovskite battery | 华东理工大学 | 2023-07-07 | — | — | CN | claimed |
| CN-113264850-A | Synthetic method of nootropic ketonic A | 安徽农业大学 | 2021-08-17 | — | — | CN | claimed |
| CN-114805108-B | Preparation method of chiral beta-alkylamide compound | 南方科技大学 | 2023-12-26 | — | — | CN | disclosed |
| US-20230271988-A1 | METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2023-08-31 | — | — | US | disclosed |
| EP-4219457-A1 | 3-(2H)-PYRIDAZINONE DERIVATIVES, THEIR COMPOSITIONS AND METHODS FOR VIRAL SENSITIZATION | Ottawa Hospital Research Institute (CA) | 2023-08-02 | — | — | EP | disclosed |
| WO-2023110154-A1 | METHOD FOR PRODUCING A HIGHLY ABRASION-RESISTANT, COATED MATERIAL WITH A CONVERSION LAYER ON AN, IN PARTICULAR STRIP-SHAPED, ALUMINIUM SUBSTRATE | ALANOD GMBH & CO. KG (DE) | 2023-06-22 | — | — | WO | disclosed |
| CN-114805108-A | Preparation method of chiral beta-alkyl amide compound | 南方科技大学 | 2022-07-29 | — | — | CN | disclosed |
| US-11339146-B2 | Compositions and methods for viral sensitization | Ottawa Hospital Research Institute and University of Ottawa (CA) | 2022-05-24 | — | — | US | disclosed |
| CN-113264850-A | Synthetic method of nootropic ketonic A | 安徽农业大学 | 2021-08-17 | — | — | CN | disclosed |
| EP-3523297-B1 | NOVEL FURAZAN-3-CARBOXYLIC ACID DERIVATIVES AND USE THEREOF IN TREATMENT OF CANCER | UNIV BERLIN FREIE (DE) | 2021-07-07 | — | — | EP | disclosed |
| US-20200354351-A1 | COMPOSITIONS AND METHODS FOR VIRAL SENSITIZATION | OTTAWA HOSPITAL RESEARCH INSTITUTE (CA) | 2020-11-12 | — | — | US | disclosed |
| WO-1996007405-A1 | EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1996-03-14 | — | — | WO | disclosed |
| US-5455260-A | Anticholesterol agents; reduction of serum cholesterol without reducing mevalonic metabolite synthesis; side effect | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1995-10-03 | — | — | US | disclosed |
| WO-1994027601-A1 | ALIPHATIC AMINO BIS-ARYL SQUALENE SYNTHASE INHIBITORS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1994-12-08 | — | — | WO | disclosed |
| WO-1994003168-A1 | 5 S PENEM DERIVATIVES, THEIR PREPARATION AND USE | SMITHKLINE BEECHAM PLC (GB) | 1994-02-17 | — | — | WO | disclosed |
| US-4920221-A | CENTRAL NERVOUS SYSTEM ACTIVE AGENTS | PFIZER INC. (US) | 1990-04-24 | — | — | US | disclosed |
| US-4642373-A | Substituted dodecahydrotripheylenes, and decahydropyrrolo[1,2-f]phenanthridines as CNS agents | PFIZER INC. (US) | 1987-02-10 | — | — | US | disclosed |
| US-4576964-A | ANALGESICS, ANTIEMETICS | PFIZER INC. (US) | 1986-03-18 | — | — | US | disclosed |
| US-4476131-A | ANTIEMETICS, ANALGESICS | PFIZER INC. (US) | 1984-10-09 | — | — | US | disclosed |
| US-4473704-A | ANALGESICS, ANTIEMETICS | PFIZER INC. (US) | 1984-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230271988-A1 | METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE | HPD, TALDO1, OGG1 | ALDH1A1 1554/4885HPGD 166/4885ALOX15 380/4885 |
| US-11339146-B2 | Compositions and methods for viral sensitization | CD4, CD74, HLA-DRB1 | ALDH1A1 3190/4885HPGD 3340/4885ALOX15 1694/4885 |
| US-20200354351-A1 | COMPOSITIONS AND METHODS FOR VIRAL SENSITIZATION | CD4, CD74, HAVCR2 | ALDH1A1 4002/4885HPGD 4356/4885ALOX15 2604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.